Daniel Thomas-Rüddel

Daniel Thomas-Rüddel

Auto-generated profile, based on publicly available information

Daniel Thomas-Rüddel

Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2021 in Chest
Verified
Journal Article
Open access
DTDaniel O. Thomas-Rüddel
Daniel O. Thomas-Rüddel
PSPeter Schlattmann
Peter Schlattmann
MPMathias Pletz
Mathias Pletz
OKOliver Kurzai
Oliver Kurzai
FBFrank Bloos
Frank Bloos
Current guidelines recommend empirical antifungal therapy in patients with sepsis with high risk of invasive Candida infection. However, many different risk factors have been derived from multiple studies. These risk factors lack specificity, and broad application would render most ICU patients eligible for empirical antifungal therapy. What risk factors for invasive Candida infection can be identified by a systematic review and meta-analysis? We searched PubMed, Web of Science, ScienceDirect, Biomed Central, and Cochrane and extracted the raw and adjusted OR for each risk factor associated with invasive Candida infection. We calculated pooled ORs for risk factors present in more than one study. We included 34 studies in our meta-analysis resulting in the assessment of 29 possible risk factors. Risk factors for invasive Candida infection included demographic factors, comorbid conditions, and medical interventions. Although demographic factors do not play a role for the development of invasive Candida infection, comorbid conditions (eg, HIV, Candida colonization) and medical interventions have a significant impact. The risk factors associated with the highest risk for invasive Candida infection were broad-spectrum antibiotics (OR, 5.6; 95% CI, 3.6-8.8), blood transfusion (OR, 4.9; 95% CI, 1.5-16.3), Candida colonization (OR, 4.7; 95% CI, 1.6-14.3), central venous catheter (OR, 4.7; 95% CI, 2.7-8.1), and total parenteral nutrition (OR, 4.6; 95% CI, 3.3-6.3). However, dependence between the various risk factors is probably high. Our systematic review and meta-analysis identified patient- and treatment-related factors that were associated with the risk for the development of invasive Candida infection in the ICU. Most of the factors identified were either related to medical interventions during intensive care or to comorbid conditions.

3 March 2014 in Critical Care
Verified
Journal Article
Open access
PDF file
FBFrank Bloos
Frank Bloos
DTDaniel Thomas-Rüddel
Daniel Thomas-Rüddel
HRHendrik Rueddel
Hendrik Rueddel
CEChristoph Engel
Christoph Engel
DSDaniel Schwarzkopf
Daniel Schwarzkopf
FGfor the MEDUSA Study Group
for the MEDUSA Study Group
Introduction: Current sepsis guidelines recommend antimicrobial treatment (AT) within one hour after onset of sepsis-related organ dysfunction (OD) and surgical source control within 12 hours. The objective of this study was to explore the association between initial infection management according to sepsis treatment recommendations and patient outcome. Methods: In a prospective observational multi-center cohort study in 44 German ICUs, we studied 1,011 patients with severe sepsis or septic shock regarding times to AT, source control, and adequacy of AT. Primary outcome was 28-day mortality. Results: Median time to AT was 2.1 (IQR 0.8 – 6.0) hours and 3 hours (-0.1 – 13.7) to surgical source control. Only 370 (36.6%) patients received AT within one hour after OD in compliance with recommendation. Among 422 patients receiving surgical or interventional source control, those who received source control later than 6 hours after onset of OD had a significantly higher 28-day mortality than patients with earlier source control (42.9% versus 26.7%, P <0.001). Time to AT was significantly longer in ICU and hospital non-survivors; no linear relationship was found between time to AT and 28-day mortality. Regardless of timing, 28-day mortality rate was lower in patients with adequate than non-adequate AT (30.3% versus 40.9%, P < 0.001). Conclusions: A delay in source control beyond 6 hours may have a major impact on patient mortality. Adequate AT is associated with improved patient outcome but compliance with guideline recommendation requires improvement. There was only indirect evidence about the impact of timing of AT on sepsis mortality.

1 October 2016 in Journal of Critical Care
Verified
Journal Article
Closed access
CMClaudia Moeller
Claudia Moeller
CFCarolin Fleischmann
Carolin Fleischmann
DTDaniel Thomas-Rueddel
Daniel Thomas-Rueddel
VVVlasislav Vlasakov
Vlasislav Vlasakov
BRBram Rochwerg
Bram Rochwerg
CHChristiane S. Hartog
Christiane S. Hartog

13 May 2018 in Critical Care
Verified
Journal Article
Open access
PDF file
FGfor the MEDUSA study group
for the MEDUSA study group
DTDaniel O. Thomas-Rüddel
Daniel O. Thomas-Rüddel
BPBernhard Poidinger
Bernhard Poidinger
MKMatthias Kott
Matthias Kott
MWManfred Weiss
Manfred Weiss
FBFrank Bloos
Frank Bloos
This study aimed to evaluate the accuracy of procalcitonin (PCT) serum concentrations to diagnose Gram-negative bacteremia and the association of PCT serum concentrations with more specific pathogens and the focus of infection. Secondary analysis of the prospectively collected patient-level dataset from a cluster randomized quality improvement trial was performed. The trial included sepsis patients with organ dysfunction treated in the participating intensive care units from 2011 to 2015. Test performance for the prediction of Gram-negative bacteremia was assessed by receiver operating curve analysis. Independent effects of specific pathogen groups and foci of infection on PCT concentrations were assessed by linear logistic regression models. Blood cultures (BC) and PCT concentrations had been taken in 4858 of 6561 documented patients. PCT was significantly higher in Gram-negative bacteremia compared to Gram-positive bacteremia or candidemia (p < 0.001). The area under the curve was 0.72 (95% confidence interval 0.71–0.74) for the prediction of Gram-negative bacteremia compared to all other blood culture results including negative blood cultures. The optimized cutoff value was 10 ng/ml (sensitivity 69%, specificity 35%). PCT differed significantly between specific groups of pathogens (p < 0.001) with highest concentrations in Escherichia coli, Streptococcus species and other Enterobacteriaceae. PCT was highest in urogenital followed by abdominal infection and lowest in respiratory infection (p < 0.001). In a linear regression model, Streptococci, E. coli and other Enterobacteriaceae detected from BC were associated with three times higher PCT values. Urogenital or abdominal foci of infection were associated with twofold increased PCT values independent of the pathogen. Serum PCT concentrations are higher in patients with Gram-negative bacteremia than in patients with Gram-positive bacteremia or candidemia. However, the discriminatory power of this difference is too low to guide therapeutic decisions. Variations in PCT serum concentrations are not determined solely by Gram-negative or Gram-positive bacteria but are also affected by distinct groups of pathogens and different foci of infection. ClinicalTrials.gov, NCT01187134 . Registered on 23 August 2010.

1 July 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
DTDaniel Thomas
Daniel Thomas
GBGjon Blakqori
Gjon Blakqori
VWValentina Wagner
Valentina Wagner
MBMarius Banholzer
Marius Banholzer
NKNina Kessler
Nina Kessler
FWFriedemann Weber
Friedemann Weber
Many viruses subvert the cellular interferon (IFN) system with so-called IFN antagonists. Bunyamwera virus (BUNV) belongs to the family Bunyaviridae and is transmitted by arthropods. We have recently identified the nonstructural protein NSs of BUNV as a virulence factor that inhibits IFN-β gene expression in the mammalian host. Here, we demonstrate that NSs targets the RNA polymerase II (RNAP II) complex. The C-terminal domain (CTD) of RNAP II consists of 52 repeats of the consensus sequence YSPTSPS. Phosphorylation at serine 5 is required for efficient initiation of transcription, and subsequent phosphorylation at serine 2 is required for mRNA elongation and 3′-end processing. In BUNV-infected mammalian cells, serine 5 phosphorylation occurred normally. Furthermore, RNAP II was able to bind to the IFN-β gene promoter as revealed by chromatin immunoprecipitation analysis, indicating that the initiation of transcription was not disturbed by NSs. However, NSs prevented CTD phosphorylation at serine 2, suggesting a block in transition from initiation to elongation. Surprisingly, no interference with CTD phosphorylation was observed in insect cells. Our results indicate that BUNV uses an unconventional mechanism to block IFN synthesis in the mammalian host by directly dysregulating RNAP II. Moreover, by inducing a general transcriptional block, NSs may contribute to the lytic infection observed in mammalian cells as opposed to persistent infection in the insect host.

18 April 2012 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
DTD. O. Thomas-Rueddel
D. O. Thomas-Rueddel
VVV. Vlasakov
V. Vlasakov
KRKonrad Reinhart
Konrad Reinhart
RJR. Jaeschke
R. Jaeschke
HRH. Rueddel
H. Rueddel
CHC. S. Hartog
C. S. Hartog